These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7228032)

  • 1. Phenotypic interaction studies of HPRT mutant and normal human fibroblasts.
    Willers I; Singh S; Goedde HW
    Hum Genet; 1981; 57(2):189-91. PubMed ID: 7228032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in fibroblasts of patients with the Lesch-Nyhan syndrome and HPRT variants. Correlation of HPRT activity with hypoxanthine utilization and growth in selection media.
    Willers I; Singh S; Goedde HW
    Enzyme; 1984; 32(4):241-7. PubMed ID: 6526001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in human HPRT and its relationship to neurologic and behavioral manifestations.
    Bakay B; Nissinen E; Sweetman L; Francke U; Nyhan WL
    Adv Exp Med Biol; 1980; 122A():317-25. PubMed ID: 7424650
    [No Abstract]   [Full Text] [Related]  

  • 4. Altered membrane NTPase activity in Lesch-Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT-deficient cell lines.
    Pinto CS; Jinnah HA; Shirley TL; Nyhan WL; Seifert R
    J Neurochem; 2005 Jun; 93(6):1579-86. PubMed ID: 15935074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: specific labeling of nucleic acids of intracellular parasites in Lesch-Nyhan cells.
    Pfefferkorn ER; Pfefferkorn LC
    Exp Parasitol; 1977 Feb; 41(1):95-104. PubMed ID: 851481
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: identification of point mutations in Japanese patients with Lesch-Nyhan syndrome and hereditary gout and their permanent expression in an HPRT-deficient mouse cell line.
    Tohyama J; Nanba E; Ohno K
    Hum Genet; 1994 Feb; 93(2):175-81. PubMed ID: 8112742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of purine utilization in cultured fibroblasts, amniocytes and chorionic villi: an attempt towards understanding clinical variability in Lesch-Nyhan syndrome.
    Singh S; Willers I; Held K; Godde HW
    Adv Exp Med Biol; 1986; 195 Pt A():143-51. PubMed ID: 3728147
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and biochemical correlates of a new HPRT mutation.
    Gruber HE; Vuchinich M; Marlow TA; Plent MM; Willis RC; Seegmiller JE; Bartley J; Hanson JW; Zellweger H
    Adv Exp Med Biol; 1984; 165 Pt A():19-22. PubMed ID: 6720378
    [No Abstract]   [Full Text] [Related]  

  • 10. High HPRT activity in fibroblasts from patients with Lesch-Nyhan syndrome due to bacterial "L-form" contamination.
    Willers I; Singh S; Held KR; Goedde HW
    Adv Exp Med Biol; 1980; 122A():327-31. PubMed ID: 7424651
    [No Abstract]   [Full Text] [Related]  

  • 11. Lesch-Nyhan syndrome: biochemical characterization of a case with attenuated behavioral manifestation.
    Fattal A; Spirer Z; Zoref-Shani E; Sperling O
    Enzyme; 1984; 31(1):55-60. PubMed ID: 6201351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxanthine salvage in man: its importance in urate overproduction in the Lesch-Nyhan syndrome.
    Edwards NL; Recker DP; Fox IH
    Adv Exp Med Biol; 1980; 122A():301-6. PubMed ID: 7424648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain purines in a genetic mouse model of Lesch-Nyhan disease.
    Jinnah HA; Page T; Friedmann T
    J Neurochem; 1993 Jun; 60(6):2036-45. PubMed ID: 8492116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate enzyme activity in erythocytes and leukocytes. A variant of hypoxanthine phosphoribosyl-transferase deficiency with an unstable enzyme.
    Dancis J; Yip LC; Cox RP; Piomelli S; Balis ME
    J Clin Invest; 1973 Aug; 52(8):2068-74. PubMed ID: 4352580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular, biochemical, and genetic characterization of a female patient with Lesch-Nyhan disease.
    Rinat C; Zoref-Shani E; Ben-Neriah Z; Bromberg Y; Becker-Cohen R; Feinstein S; Sperling O; Frishberg Y
    Mol Genet Metab; 2006 Mar; 87(3):249-52. PubMed ID: 16343967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of hypoxanthine by PHA-stimulated HPRT-deficient lymphocytes.
    Cox RP; Krauss MR; Balis ME; Yip LC; Jansen V; Dancis J
    Exp Cell Res; 1974 Oct; 88(2):289-94. PubMed ID: 4426333
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.
    Jinnah HA; Langlais PJ; Friedmann T
    J Pharmacol Exp Ther; 1992 Nov; 263(2):596-607. PubMed ID: 1432691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxanthine accumulation and dopamine depletion in Lesch-Nyhan disease.
    Palmour RM; Heshka TW; Ervin FR
    Adv Exp Med Biol; 1989; 253A():165-72. PubMed ID: 2624186
    [No Abstract]   [Full Text] [Related]  

  • 19. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.
    Kuehn MR; Bradley A; Robertson EJ; Evans MJ
    Nature; 1987 Mar 19-25; 326(6110):295-8. PubMed ID: 3029599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine metabolism in permanent lymphocyte lines and in erythrocytes of patients with the Lesch-Nyhan syndrome.
    Reem GH
    Adv Exp Med Biol; 1977; 76A():384-90. PubMed ID: 855718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.